Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0298-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Targeting Checkpoint Kinase 1 in Cancer Therapeutics

Clinical Cancer Research
Cancer ResearchOncology
2007English

Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2020English

The FG Loop of PD-1 Serves as a ‘Hot-Spot’ for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy

iScience
Multidisciplinary
2019English

Co-Targeting Aurora Kinase With PD-L1 and PI3K Abrogates Immune Checkpoint Mediated Proliferation in Peripheral T-Cell Lymphoma: A Novel Therapeutic Strategy

Oncotarget
Oncology
2017English

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The Prognostic Role of Immune Checkpoint Markers Programmed Cell Death Protein 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) in a Large, Multicenter Prostate Cancer Cohort

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy